{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T10:09:48Z","timestamp":1780308588273,"version":"3.54.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100020621","name":"Seoul St. Mary's Hospital, Catholic University of Korea","doi-asserted-by":"publisher","award":["ZC23TISI0770"],"award-info":[{"award-number":["ZC23TISI0770"]}],"id":[{"id":"10.13039\/501100020621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"crossref","award":["RS-2023-00253065"],"award-info":[{"award-number":["RS-2023-00253065"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Ophthalmol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s10384-026-01330-7","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T04:15:59Z","timestamp":1770092159000},"page":"641-648","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u03b1-Crystallins and vascular endothelial growth factor in aqueous humor of patients with neovascular age-related macular degeneration"],"prefix":"10.1007","volume":"70","author":[{"given":"Joo Young","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su Been","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongtae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9553-3069","authenticated-orcid":false,"given":"Young-Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"1330_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/cells11213453","volume":"11","author":"H Heloter\u00e4","year":"2022","unstructured":"Heloter\u00e4 H, Kaarniranta K. A linkage between angiogenesis and inflammation in neovascular age-related macular degeneration. Cells. 2022;11:3453.","journal-title":"Cells"},{"key":"1330_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/biom12111629","volume":"12","author":"RH ElSheikh","year":"2022","unstructured":"ElSheikh RH, Chauhan MZ, Sallam AB. Current and novel therapeutic approaches for treatment of neovascular age-related macular degeneration. Biomolecules. 2022;12:1629.","journal-title":"Biomolecules"},{"key":"1330_CR3","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392:1147\u201359.","journal-title":"Lancet"},{"key":"1330_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22031296","volume":"22","author":"Y Ruan","year":"2021","unstructured":"Ruan Y, Jiang S, Gericke A. Age-related macular degeneration: role of oxidative stress and blood vessels. Int J Mol Sci. 2021;22:1296.","journal-title":"Int J Mol Sci"},{"key":"1330_CR5","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.oret.2018.01.006","volume":"2","author":"TA Ciulla","year":"2018","unstructured":"Ciulla TA, Huang F, Westby K, Williams DF, Zaveri S, Patel SC. Real-world outcomes of anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration in the United States. Ophthalmol Retina. 2018;2:645\u201353.","journal-title":"Ophthalmol Retina"},{"key":"1330_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112436","volume":"10","author":"P Patel","year":"2021","unstructured":"Patel P, Sheth V. New and innovative treatments for neovascular age-related macular degeneration (nAMD). J Clin Med. 2021;10:2436.","journal-title":"J Clin Med"},{"key":"1330_CR7","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.3390\/antiox10071001","volume":"10","author":"AS Phadte","year":"2021","unstructured":"Phadte AS, Sluzala ZB, Fort PE. Therapeutic potential of alpha-crystallins in retinal neurodegenerative diseases. Antioxidants (Basel). 2021;10:1001.","journal-title":"Antioxidants (Basel)"},{"key":"1330_CR8","first-page":"410","volume":"9","author":"J Xi","year":"2003","unstructured":"Xi J, Farjo R, Yoshida S, Kern TS, Swaroop A, Andley UP. A comprehensive analysis of the expression of crystallins in mouse retina. Mol Vis. 2003;9:410\u20139.","journal-title":"Mol Vis"},{"key":"1330_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3892\/mmr.2024.13387","volume":"31","author":"L Wang","year":"2025","unstructured":"Wang L, Li X, Men X, Liu X, Luo J. Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review). Mol Med Rep. 2025;31:22.","journal-title":"Mol Med Rep"},{"key":"1330_CR10","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1146\/annurev-physchem-090419-121428","volume":"72","author":"MA Sprague-Piercy","year":"2021","unstructured":"Sprague-Piercy MA, Rocha MA, Kwok AO, Martin RW. alpha-Crystallins in the vertebrate eye lens: complex oligomers and molecular chaperones. Annu Rev Phys Chem. 2021;72:143\u201363.","journal-title":"Annu Rev Phys Chem"},{"key":"1330_CR11","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jmb.2007.06.060","volume":"372","author":"S Meehan","year":"2007","unstructured":"Meehan S, Knowles TP, Baldwin AJ, Smith JF, Squires AM, Clements P, et al. Characterisation of amyloid fibril formation by small heat-shock chaperone proteins human alphaA-, alphaB- and R120G alphaB-crystallins. J Mol Biol. 2007;372:470\u201384.","journal-title":"J Mol Biol"},{"key":"1330_CR12","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1002\/prca.201200012","volume":"7","author":"J Yao","year":"2013","unstructured":"Yao J, Liu X, Yang Q, Zhuang M, Wang F, Chen X, et al. Proteomic analysis of the aqueous humor in patients with wet age-related macular degeneration. Proteomics Clin Appl. 2013;7:550\u201360.","journal-title":"Proteomics Clin Appl"},{"key":"1330_CR13","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.exer.2004.12.011","volume":"80","author":"K Nakata","year":"2005","unstructured":"Nakata K, Crabb JW, Hollyfield JG. Crystallin distribution in Bruch\u2019s membrane-choroid complex from AMD and age-matched donor eyes. Exp Eye Res. 2005;80:821\u20136.","journal-title":"Exp Eye Res"},{"key":"1330_CR14","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1182\/blood-2009-01-197095","volume":"115","author":"S Kase","year":"2010","unstructured":"Kase S, He S, Sonoda S, Kitamura M, Spee C, Wawrousek E, et al. alphaB-crystallin regulation of angiogenesis by modulation of VEGF. Blood. 2010;115:3398\u2013406.","journal-title":"Blood"},{"key":"1330_CR15","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1167\/iovs.14-14447","volume":"55","author":"S Sonoda","year":"2014","unstructured":"Sonoda S, Sakamoto T, Yamashita T, Shirasawa M, Uchino E, Terasaki H, et al. Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Invest Ophthalmol Vis Sci. 2014;55:3893\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1330_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08276-4","volume":"7","author":"DSW Ting","year":"2017","unstructured":"Ting DSW, Yanagi Y, Agrawal R, Teo HY, Seen S, Yeo IYS, et al. Choroidal remodeling in age-related macular degeneration and polypoidal choroidal vasculopathy: a 12-month prospective study. Sci Rep. 2017;7:7868.","journal-title":"Sci Rep"},{"key":"1330_CR17","first-page":"4","volume":"7","author":"A Tomi","year":"2014","unstructured":"Tomi A, Marin I. Angiofluorographic aspects in age-related macular degeneration. J Med Life. 2014;7:4\u201317.","journal-title":"J Med Life"},{"key":"1330_CR18","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1038\/s41433-022-02231-y","volume":"37","author":"T Mathis","year":"2023","unstructured":"Mathis T, Holz FG, Sivaprasad S, Yoon YH, Eter N, Chen LJ, et al. Characterisation of macular neovascularisation subtypes in age-related macular degeneration to optimise treatment outcomes. Eye (Lond). 2023;37:1758\u201365.","journal-title":"Eye (Lond)"},{"key":"1330_CR19","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, et al. Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology. 2018;125:708\u201324.","journal-title":"Ophthalmology"},{"key":"1330_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00904-4","volume":"11","author":"JY Kim","year":"2021","unstructured":"Kim JY, Son WY, Kim RY, Kim M, Park YG, Park YH. Recurrence and visual prognostic factors of polypoidal choroidal vasculopathy: 5-year results. Sci Rep. 2021;11:21572.","journal-title":"Sci Rep"},{"key":"1330_CR21","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0045-22.2022","volume":"9","author":"M Nath","year":"2022","unstructured":"Nath M, Sluzala ZB, Phadte AS, Shan Y, Myers AM, Fort PE. Evidence for paracrine protective role of exogenous alphaa-crystallin in retinal ganglion cells. ENeuro. 2022;9:0045-22.2022.","journal-title":"ENeuro"},{"key":"1330_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.bbagen.2015.05.016","volume":"1860","author":"R Kannan","year":"2016","unstructured":"Kannan R, Sreekumar PG, Hinton DR. Alpha crystallins in the retinal pigment epithelium and implications for the pathogenesis and treatment of age-related macular degeneration. Biochim Biophys Acta. 2016;1860:258\u201368.","journal-title":"Biochim Biophys Acta"},{"key":"1330_CR23","doi-asserted-by":"publisher","first-page":"3181","DOI":"10.1182\/blood-2010-01-262766","volume":"115","author":"BA Kerr","year":"2010","unstructured":"Kerr BA, Byzova TV. AlphaB-crystallin: a novel VEGF chaperone. Blood. 2010;115:3181\u20133.","journal-title":"Blood"},{"key":"1330_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10549-014-2940-8","volume":"145","author":"Z Chen","year":"2014","unstructured":"Chen Z, Ruan Q, Han S, Xi L, Jiang W, Jiang H, et al. Discovery of structure-based small molecular inhibitor of alphaB-crystallin against basal-like\/triple-negative breast cancer development in vitro and in vivo. Breast Cancer Res Treat. 2014;145:45\u201359.","journal-title":"Breast Cancer Res Treat"},{"key":"1330_CR25","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1042\/BJ20060981","volume":"401","author":"H Ecroyd","year":"2007","unstructured":"Ecroyd H, Meehan S, Horwitz J, Aquilina JA, Benesch JL, Robinson CV, et al. Mimicking phosphorylation of alphaB-crystallin affects its chaperone activity. Biochem J. 2007;401:129\u201341.","journal-title":"Biochem J"},{"key":"1330_CR26","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.64.10.20","volume":"64","author":"T Yamamoto","year":"2023","unstructured":"Yamamoto T, Kase S, Shinkai A, Murata M, Kikuchi K, Wu D, et al. Phosphorylation of \u03b1B-crystallin involves interleukin-1\u03b2-mediated intracellular retention in retinal muller cells: a new mechanism underlying fibrovascular membrane formation. Invest Ophthalmol Vis Sci. 2023;64:20.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1330_CR27","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1182\/blood-2007-04-087841","volume":"111","author":"A Dimberg","year":"2008","unstructured":"Dimberg A, Rylova S, Dieterich LC, Olsson AK, Schiller P, Wikner C, et al. alphaB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis. Blood. 2008;111:2015\u201323.","journal-title":"Blood"},{"key":"1330_CR28","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.bbrc.2006.12.152","volume":"354","author":"S Liu","year":"2007","unstructured":"Liu S, Li J, Tao Y, Xiao X. Small heat shock protein alphaB-crystallin binds to p53 to sequester its translocation to mitochondria during hydrogen peroxide-induced apoptosis. Biochem Biophys Res Commun. 2007;354:109\u201314.","journal-title":"Biochem Biophys Res Commun"},{"key":"1330_CR29","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.1091\/mbc.e05-01-0010","volume":"16","author":"DWC Li","year":"2005","unstructured":"Li DWC, Liu JP, Mao YW, Xiang H, Wang J, Ma WY, et al. Calcium-activated RAF\/MEK\/ERK signaling pathway mediates p53-dependent apoptosis and is abrogated by \u03b1B-crystallin through inhibition of RAS activation. Mol Biol Cell. 2005;16:4437\u201353.","journal-title":"Mol Biol Cell"},{"key":"1330_CR30","first-page":"3575","volume":"43","author":"CS Alge","year":"2002","unstructured":"Alge CS, Priglinger SG, Neubauer AS, Kampik A, Zillig M, Bloemendal H, et al. Retinal pigment epithelium is protected against apoptosis by \u03b1B-crystallin. Invest Ophth Vis Sci. 2002;43:3575\u201382.","journal-title":"Invest Ophth Vis Sci."},{"key":"1330_CR31","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/ceo.12891","volume":"45","author":"W Chen","year":"2017","unstructured":"Chen W, Lu Q, Lu L, Guan H. Increased levels of alphaB-crystallin in vitreous fluid of patients with proliferative diabetic retinopathy and correlation with vascular endothelial growth factor. Clin Exp Ophthalmol. 2017;45:379\u201384.","journal-title":"Clin Exp Ophthalmol"},{"key":"1330_CR32","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1167\/iovs.15-16418","volume":"56","author":"N Celik","year":"2015","unstructured":"Celik N, Scheuerle A, Auffarth GU, Kopitz J, Dithmar S. Intraocular pharmacokinetics of aflibercept and vascular endothelial growth factor-a. Invest Ophthalmol Vis Sci. 2015;56:5574\u20138.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1330_CR33","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/eye.2014.94","volume":"28","author":"J Hanhart","year":"2014","unstructured":"Hanhart J, Tiosano L, Averbukh E, Banin E, Hemo I, Chowers I. Fellow eye effect of unilateral intravitreal bevacizumab injection in eyes with diabetic macular edema. Eye (Lond). 2014;28:646\u201353.","journal-title":"Eye (Lond)"}],"container-title":["Japanese Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01330-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10384-026-01330-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10384-026-01330-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T09:54:56Z","timestamp":1780307696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10384-026-01330-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["1330"],"URL":"https:\/\/doi.org\/10.1007\/s10384-026-01330-7","relation":{},"ISSN":["0021-5155","1613-2246"],"issn-type":[{"value":"0021-5155","type":"print"},{"value":"1613-2246","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"assertion":[{"value":"25 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"J. Y. Kim, None; J. Lee, None; S. B. Oh, None; C. Kim, None; Y-H. Park, None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}